Keyphrases
Hepatitis C Virus
100%
Serine Protease
31%
Hepatocellular Carcinoma
24%
NS2B-NS3 Protease
24%
Liver Transplantation
23%
Hepatitis B Virus
21%
Vitamin D
20%
Gene Expression
17%
Hepatitis C Virus Infection
17%
Hepatitis C Virus RNA
16%
Hepatocellular Carcinoma Cells
14%
Lamivudine
14%
Cardiomyocytes
14%
Lamivudine Resistance
14%
Induced Damage
13%
Leptin
13%
Cell Transformation
13%
Toll-like
13%
Fulminant Hepatic Failure
13%
Sorafenib
13%
Protease Activity
13%
Virus-infected Cell
13%
Hepatitis B Virus Infection
12%
Viral
12%
Recombinant
12%
Single-chain Antibody
11%
Antiretroviral Therapy
10%
Liver
10%
Vitamin D3
10%
Interferon-α (IFN-α)
10%
Intrabody
10%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
Hepatoma Cells
10%
Chronic Hepatitis C Virus Infection
9%
Adipose Tissue
9%
Serine Protease Inhibitor
9%
Hepatitis B Virus Replication
9%
Hepatocellular Carcinoma Tissues
9%
Phenotypic Change
9%
Recurrent Hepatitis
9%
Hepatitis B Virus DNA
9%
Calcitriol
9%
RNA Replicon
8%
Virus Production
8%
Hepatic Injury
8%
Insulin
8%
Chronic Hepatitis
8%
Intracellular Antibody
8%
Chronic Hepatitis C
8%
Hepatitis G Virus
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
54%
Liver Cell Carcinoma
44%
Hepatitis B Virus
38%
Lamivudine
20%
Serine Proteinase
20%
Liver Injury
15%
Hepatitis B
15%
Proteinase
15%
Vitamin D
14%
Toll Like Receptor 4
13%
Sorafenib
13%
Cholecalciferol
9%
Lipopolysaccharide
9%
Interferon
9%
Ischemia
8%
Antivirus Agent
8%
Infection
7%
Serine Proteinase Inhibitor
7%
Receptor
7%
Hepatitis C
7%
Chronic Hepatitis C
7%
Calcitriol
7%
Heme Oxygenase 1
7%
Flavonoid
6%
Quercetin
6%
Disease Exacerbation
6%
Viremia
6%
Leptin
6%
Alloxan
6%
25 Hydroxyvitamin D
6%
Bacterial Toxin
6%
Uridine Triphosphate
6%
Reperfusion Injury
6%
Liver Fibrosis
6%
Hepatitis G Virus
6%
Hepatitis G
6%
Mitogen Activated Protein Kinase 14
6%
Galactosamine
6%
Fulminant Hepatic Failure
6%
Tumor Virus
6%
Retinol
6%
Thalassemia
6%
Diabetic Cardiomyopathy
6%
Zebra Fish
6%
Endotoxemia
6%
Streptozotocin
6%
High-Throughput Screening
6%
Nonalcoholic Fatty Liver
6%
Uridine
6%
Hepacivirus
6%
Medicine and Dentistry
Hepatitis B Virus
32%
Hepatocellular Carcinoma
30%
Hepatitis C Virus
24%
Liver Transplantation
21%
Liver Injury
14%
Lamivudine
13%
Toll Like Receptor 4
13%
Sorafenib
13%
Hepatitis B
12%
Fulminant Hepatic Failure
11%
Hepatocyte
10%
Gene Expression
10%
Hepatoma Cell
9%
Lipopolysaccharide
9%
Hepatitis Virus
8%
Hepatitis G Virus
7%
Infection
7%
Fulminant
7%
Cell Signaling Pathway
7%
Carcinoma Cell
7%
Adipose Tissue
7%
Chronic Hepatitis C
7%
Viremia
6%
Leptin
6%
Ischemia
6%
P73
6%
Thalassemia
6%
Mitogen Activated Protein Kinase 14
6%
Genetic Heterogeneity
6%
Tumor Virus
6%
Anesthesiologist
6%
Cardiac Muscle Cell
6%
Liver Fibrosis
6%
Mesenchymal Stem Cell
6%
Hepatitis G
6%
Galactosamine
6%
Endotoxemia
6%
Vitamin D
6%
Disease Exacerbation
6%
Nonalcoholic Fatty Liver
6%
Induced Resistance
6%
Cell Signaling
6%
Carcinogenesis
6%
Lenvatinib
6%
Cell Viability
6%
Cell Transformation
6%
Serine Proteinase
6%
Messenger RNA
5%
Interferon
5%
Liver Enzyme
5%